Access to anti-retroviral drugs, female in Maldives
Maldives: Access to anti-retroviral drugs, female was 21.0% in 2024. ◆ Volatile
Access to anti-retroviral drugs, female in Maldives, 2000–2024
Source: UNAIDS estimates. Measured in %.
Analysis
The most recent figure for access to anti-retroviral drugs, female in Maldives is 21.0%, measured in 2024.
The figure is down 4.5% on the previous year and up 110.0% over ten years.
Over the whole period, access to anti-retroviral drugs, female in Maldives peaked at 31.0% in 2007 and was at its lowest, 0.0%, in 2000.
That places Maldives 138th out of 141 countries with data for 2024, putting it in the bottom quarter.
The series is highly variable year to year, so single readings are best treated with caution.
Access to anti-retroviral drugs, female in Maldives, year by year
| Year | % | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 0.0% | — |
| 2002 | 0.0% | — |
| 2003 | 0.0% | — |
| 2004 | 0.0% | — |
| 2005 | 0.0% | — |
| 2006 | 0.0% | — |
| 2007 | 31.0% | — |
| 2008 | 29.0% | -6.5% |
| 2009 | 27.0% | -6.9% |
| 2010 | 0.0% | -100.0% |
| 2011 | 0.0% | — |
| 2012 | 0.0% | — |
| 2013 | 0.0% | — |
| 2014 | 10.0% | — |
| 2015 | 10.0% | +0.0% |
| 2016 | 9.0% | -10.0% |
| 2017 | 9.0% | +0.0% |
| 2018 | 24.0% | +166.7% |
| 2019 | 22.0% | -8.3% |
| 2020 | 21.0% | -4.5% |
| 2021 | 19.0% | -9.5% |
| 2022 | 18.0% | -5.3% |
| 2023 | 22.0% | +22.2% |
| 2024 | 21.0% | -4.5% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 8.7% | 0.0% | 31.0% | 10 |
| 2010s | 8.4% | 0.0% | 24.0% | 10 |
| 2020s | 20.2% | 18.0% | 22.0% | 5 |
Countries ranked near Maldives
More gender data for Maldives
- Child population (UN estimates and projections) 86.61 (2030)
- Child population (UN estimates and projections) (0-14), annual growth -2.93 % change on previous year (2030)
- Population 453.06 (2030)
- Working-age population (UN estimates and projections) 453.06 (2030)
- Population (UN estimates and projections), annual growth rate 1.05 % change on previous year (2030)
- Age population, age 00, female, interpolated 2,667 (2025)
- Age population, age 00, male, interpolated 2,787 (2025)
- Age population, age 01, female, interpolated 2,752 (2025)
- Age population, age 01, male, interpolated 2,869 (2025)
- Age population, age 02, female, interpolated 2,832 (2025)
Frequently asked questions
- What is access to anti-retroviral drugs, female in Maldives?
- Access to anti-retroviral drugs, female in Maldives was 21.0% in 2024, according to UNAIDS estimates.
- What is the highest access to anti-retroviral drugs, female recorded in Maldives?
- The highest recorded value was 31.0% in 2007.
- What is the lowest access to anti-retroviral drugs, female recorded in Maldives?
- The lowest recorded value was 0.0% in 2000.
- How does Maldives rank for access to anti-retroviral drugs, female?
- Maldives ranks 138th out of 141 countries with data for 2024.
- Is access to anti-retroviral drugs, female rising or falling in Maldives?
- Over the last ten years it is up 110.0%. The long-run trend across the full record is volatile.
- Where does this Maldives data come from?
- The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, female (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.